SCHEMBL1964087

SCHEMBL1964087

OC(C(Cl)Cl)C(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL4949058 0.91 TDP1 (0.33)
SCHEMBL27926989 0.80
SCHEMBL1742988 0.74
SCHEMBL28729646 0.74
SCHEMBL6365960 0.71
Trichloroethanol SCHEMBL134202 0.71
SCHEMBL5705554 0.68
SCHEMBL23396 0.68
SCHEMBL558126 0.67
Ammonia Solution, Strong SCHEMBL9739864 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10934234-B2 Composition comprising chlorinated alkene and a process for producing the composition thereof SPOLEK PRO CHEMICKOU A HUTNI VYROBU A.S. (CZ) 2021-03-02 US disclosed
US-10927101-B2 Neopetrosides A and B, and synthesis method thereof INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2021-02-23 US disclosed
WO-2019189024-A1 METHOD FOR PRODUCING 1-CHLORO-2,3,3-TRIFLUOROPROPENE AGC株式会社 2019-10-03 WO disclosed
US-20190218206-A1 NEOPETROSIDES A AND B, AND SYNTHESIS METHOD THEREOF INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2019-07-18 US disclosed
US-20190135717-A1 PROCESS FOR PREPARING A CHLORINATED ALKENE SPOLEK PRO CHEMICKOU A HUTNI VYROBU A.S. (CZ) 2019-05-09 US disclosed
EP-3087155-A1 CONTROL OF SUSTAINED CASING PRESSURE IN WELLBORE ANNULI Albemarle Corporation (US) 2016-11-02 EP disclosed
US-20160289527-A1 CONTROL OF SUSTAINED CASING PRESSURE IN WELLBORE ANNULI ALBEMARLE CORP (US) 2016-10-06 US disclosed
WO-2015100004-A1 CONTROL OF SUSTAINED CASING PRESSURE IN WELLBORE ANNULI ALBEMARLE CORPORATION (US) 2015-07-02 WO disclosed
EP-2738172-A1 New bicyclic compounds as crac channel modulators Almirall, S.A. (ES) 2014-06-04 EP disclosed
EP-2334681-A1 1,2,3,6-TETRAHYDROAZEPINO[4,5-B]INDOLE-5-CARBOXYLATE NUCLEAR RECEPTOR INHIBITORS Wyeth LLC (US) 2011-06-22 EP disclosed
WO-2001005392-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-01-25 WO disclosed
US-6084081-A Lewis X derivatives DAIKIN INDUSTRIES, LTD. (JP) 2000-07-04 US disclosed
EP-0993439-A1 4-BROMO OR 4-IODO PHENYLAMINO BENZHYDROXAMIC ACID DERIVATIVES AND THEIR USE AS MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2000-04-19 EP disclosed
EP-0930315-A1 LEWIS X DERIVATIVES DAIKIN INDUSTRIES, LTD. (JP) 1999-07-21 EP disclosed
WO-1999001426-A1 4-BROMO OR 4-IODO PHENYLAMINO BENZHYDROXAMIC ACID DERIVATIVES AND THEIR USE AS MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 1999-01-14 WO disclosed
WO-1998037881-A1 METHOD OF TREATING OR PREVENTING SEPTIC SHOCK BY ADMINISTERING A MEK INHIBITOR WARNER LAMBERT COMPANY (US) 1998-09-03 WO disclosed
EP-0640601-B1 BENZAMIDE DERIVATIVE HOKURIKU PHARMACEUTICAL (JP) 1996-12-04 EP disclosed
US-5500422-A FOR TREATING GASTROINTESTINAL DISEASES HOKURIKU SEIYAKU CO. LTD. (JP) 1996-03-19 US disclosed
US-5395832-A Gastrointestinal disorders HOKURIKU SEIYAKU CO., LTD. (JP) 1995-03-07 US disclosed
EP-0640601-A1 BENZAMIDE DERIVATIVE HOKURIKU SEIYAKU CO., LTD. (JP) 1995-03-01 EP disclosed